Testing effectiveness (Phase 2)Study completedNCT00278382
What this trial is testing
Sorafenib in Treating Patients With Recurrent Non-Hodgkin's Lymphoma
Who this might be right for
Anaplastic Large Cell LymphomaRecurrent Adult Diffuse Large Cell LymphomaRecurrent Mantle Cell Lymphoma
National Cancer Institute (NCI) 33